As the health care debate focuses on whether cost cuts are looming in Medicare coverage, Representative Henry A. Waxman is on a crusade to save Medicare billions of dollars — in a way that he says would end up helping the elderly.
That is because the money would come from the drug industry, which is why Mr. Waxman may have a fight on his hands.
Drug makers contend they have already worked out a 10-year, $80 billion cost-savings deal with the White House and crucial Senate gatekeepers on the trillion-dollar health care overhaul. The industry says that trying to add Mr. Waxman’s provision could scuttle that agreement.
“You not only break the deal, but you break the bank for us,” said Billy Tauzin, chief executive of the drug industry’s trade group, the Pharmaceutical Research and Manufacturers of America, known as PhRMA.
At issue is a multibillion-dollar “windfall” that Mr. Waxman contends the drug industry received when drug benefits were added to Medicare coverage in 2006. Mr. Waxman, Democrat of California, is chairman of the House Energy and Commerce Committee and is central to the House’s legislative efforts on health care.
<snip>
“We don’t have any deal with them, and the whole enterprise of doing health insurance for all Americans isn’t to make the drug companies happy, or wealthier,” Mr. Waxman said. “They’re going to make a lot of money when we insure all Americans. There’s no argument for them to get a windfall.”
http://www.nytimes.com/2009/08/26/health/policy/26dual.htmlGood to see that Waxman is continuing the work of Senator Kennedy on this issue!